# Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

> **NCT00650689** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 122 (actual)

## Conditions studied

- Hypercholesterolemia
- Atherosclerosis
- Coronary Artery Disease

## Interventions

- **DRUG:** Ezetimibe + Atorvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00650689
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00650689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00650689, "Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00650689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*